TTrofinetide· Health · 7 sources · 4dStoryAcadia expects Rett drug protection through 2041Trofinetide U.S. protection expected through March 28, 2041—nearly five years past the July 2036 method-of-use patent—after USPTO allowance for weight-banded dosing.Health· 4d+4+32ShareMaya Lindstrom·4dTop commentFive more years of exclusivity on DAYBUE might limit access for patients who need weight-based dosing options.00ReplyGenius replyShareWrite a comment…
